FPF
COGT icon

FNY Partners Fund’s Cogent Biosciences COGT Stock Holding History

FNY Partners Fund’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$25K Buy
+568
New +$25.2K 0.01% 224

Other funds holding COGT

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FNY Partners Fund's COGT Position: Q1 2018 in Review

FNY Partners Fund opened a new position in Cogent Biosciences (COGT) in Q1 2018: 568 shares worth $25K. The stake represents 0.01% of the portfolio and ranks #224 among its holdings.

28 funds tracked by Wall St. Rank hold COGT as of Q1 2018.

  • FNY Partners Fund held 568 shares of Cogent Biosciences worth $25K as of Q1 2018.
  • Cogent Biosciences was a new FNY Partners Fund position in Q1 2018.
  • Cogent Biosciences made up 0.01% of FNY Partners Fund's portfolio in Q1 2018, its #224 holding.
  • 28 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.